Investing in GLP-1 Drugs: Eli Lilly, Novo Nordisk, and Viking Therapeutics in 2026 – News and Statistics
May 22, 2026 The introduction of GLP-1 weight-loss drugs by Novo Nordisk may have changed the pharmaceutical industry…
Novo Nordisk Q1 2026 Earnings: Revenue, Profit Beat; Full-Year Forecast Narrowed | Reuters – News and Statistics
May 7, 2026 Novo Nordisk, the manufacturer of the weight-loss drug Wegovy, reported first-quarter revenue and adjusted operating…